Drug Trial Radar · NCT01355497
Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line Platinum
Last checked: Nov 19, 2026Latest source record: Nov 9, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
330
Actual
Start
Jul 2011
Primary completion
May 2013
Study completion Jun 2014
Sponsor
- Lead sponsor
- GTxIndustry
- Sponsor type
- Industry
- First posted
- May 18, 2011
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 30 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine if the investigational drug GTx-024 can help patients with non small cell lung cancer increase physical function and maintain or gain muscle.
Conditions
- Muscle Wasting
- Non-Small Cell Lung Cancer
Interventions
GTx-024Drug
subjects will be randomized to receive GTx-024 3mg softgel for the duration of the trial.
placeboDrug
subject will receive matching placebo for the duration of the trial
Primary outcomes
What the sponsor says the trial is designed to measure.
- Physical FunctionTime frame: Day 84
- Lean Body MassTime frame: Day 84
Locations
30 sites in 1 country. Site status is shown where the registry gives one.
GTx Investigative Site
Birmingham, Alabama
GTx Investigative Site
Scottsdale, Arizona
GTx Investigative Site
La Jolla, California
GTx Investigative Site
Long Beach, California
GTx Investigative Site
Miami, Florida
GTx Investigative Site
Orange City, Florida
GTx Investigative Site
Tampa, Florida
GTx Investigative Site
Decatur, Illinois
GTx Investigative Site
Peoria, Illinois
GTx Investigative Site
Skokie, Illinois
GTx Investigative Site
Goshen, Indiana
GTx Investigative Site
Indianapolis, Indiana
GTx Investigative Site
Ashland, Kentucky
GTx Investigative Site
Concord, Massachusetts
GTx Investigative Site
Saint Clair Shores, Michigan
GTx Investigative Site
Tupelo, Mississippi
GTx Investigative Site
Great Falls, Montana
GTx Investigative Site
Rochester, New York
GTx Investigative Site
Burlington, North Carolina
GTx Investigator
Flat Rock, North Carolina
GTx Investigative Site
Wilmington, North Carolina
GTx Investigative Site
Winston-Salem, North Carolina
GTx Investigative Site
Canfield, Ohio
Gabrail Cancer Center
Canton, Ohio
GTx Investigative Site
Sandusky, Ohio
GTx Investigative Site
Portland, Oregon
GTx Investigative Site
Lancaster, Pennsylvania
GTx Investigative Site
Spartanburg, South Carolina
GTx Investigative Site
Nashville, Tennessee
GTx Investigative Site
Round Rock, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.